Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

NNFA Praises DSHEA Implementation Act, Promotes It As S 722 Alternative

This article was originally published in The Tan Sheet

Executive Summary

The National Nutritional Foods Association is pursuing an aggressive campaign against the "Dietary Supplement Safety Act" (S 722) using informational papers, fliers and direct-to-consumer mailings

You may also be interested in...



Ephedra Ban Reaction Cautious From Most In Industry; Overdue, Hatch Says

The dietary supplement industry is taking a wait-and-see attitude about FDA's imminent rule banning ephedrine alkaloid-containing dietary supplements

Ephedra Ban Reaction Cautious From Most In Industry; Overdue, Hatch Says

The dietary supplement industry is taking a wait-and-see attitude about FDA's imminent rule banning ephedrine alkaloid-containing dietary supplements

Ephedra Ban Reaction Cautious From Most In Industry; Overdue, Hatch Says

The dietary supplement industry is taking a wait-and-see attitude about FDA's imminent rule banning ephedrine alkaloid-containing dietary supplements

Related Content

Topics

UsernamePublicRestriction

Register

PS095795

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel